Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FD2WV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,960
Award facts
- Contract value 100% obligated
- $11,959.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,959.70 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 mg tablets (30-count unit dose packages) with an ultimate completion date of February 2, 2026. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government agencies.
This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide. RINVOQ (upadacitinib) is a Janus kinase inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, representing the type of specialty pharmaceutical products the company routinely supplies to support Defense Health Agency and military treatment facilities globally. The company's federal contract portfolio demonstrates its established capability to fulfill government medical procurement requirements across multiple therapeutic domains through open competition.
Quick answers
Who was awarded contract SPE2DR26FD2WV?
SPE2DR26FD2WV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FD2WV worth?
The government has obligated $11,960 on SPE2DR26FD2WV.
Is contract SPE2DR26FD2WV an order under another contract?
Yes. SPE2DR26FD2WV is a delivery order under SPE2DR25D2203, an indefinite delivery contract.
Was contract SPE2DR26FD2WV competed?
The extent of competition for SPE2DR26FD2WV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award